title: Drugs, devices, diagnostics, and policies: the year's review.
abstract: Throughout 1999, the Food and Drug Administration approved several new drugs and medical devices. The agency also took an active role in defining public policies regarding pharmacologic issues for the American consumer. This article provides an overview of these topics.
authors.affiliation: Regis University, Denver, Colo., USA.
authors.forename: D
authors.initials: D
authors.lastname: Kupecz
mesh_terms: D004335:Drug and Narcotic Control; D004864:Equipment and Supplies; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D011640:Public Policy; D011933:Reagent Kits, Diagnostic; D012907:Smoking / Q000331:legislation & jurisprudence; D000074606:Smoking Prevention; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004364:Pharmaceutical Preparations; D011933:Reagent Kits, Diagnostic